No abstract available
Keywords:
T regulatory cells; chronic lymphocytic leukaemia; interleukin 2; peptide vaccination; thalidomide.
Publication types
-
Clinical Trial, Phase I
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Aged
-
Aged, 80 and over
-
Cancer Vaccines
-
Case-Control Studies
-
Female
-
Humans
-
Immunity, Cellular*
-
Interleukin-2 / pharmacology
-
Leukemia, Lymphocytic, Chronic, B-Cell / immunology*
-
Leukemia, Lymphocytic, Chronic, B-Cell / therapy
-
Male
-
Middle Aged
-
T-Lymphocytes, Cytotoxic / immunology
-
T-Lymphocytes, Regulatory / immunology*
-
Thalidomide / pharmacology
-
Vaccination
-
Vaccines, Subunit
Substances
-
Cancer Vaccines
-
IL2 protein, human
-
Interleukin-2
-
Vaccines, Subunit
-
Thalidomide